Quantification of clotiazepam in human plasma by gas chromatography-mass spectrometry

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Apr 13;834(1-2):128-33. doi: 10.1016/j.jchromb.2006.02.035. Epub 2006 Mar 6.

Abstract

An analytical procedure was developed and validated for the quantification of clotiazepam in human plasma. After subjecting plasma samples to solid-phase extraction, the extract was evaporated and the residue re-constituted. An aliquot of the mixture was injected onto a gas chromatography-mass spectrometry system. The detector response was linear for clotiazepam concentrations in the range of 5-200 ng/ml. Intra- and inter-day precision for the assay over the concentration range was below 13.1 and 13.5%, and the accuracy ranged between 99.0-107.9% and 92.4-101.3%, respectively. The drug was found to be stable under various processing conditions used. The method is applicable to human pharmacokinetic studies of clotiazepam.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Azepines / blood*
  • Azepines / pharmacokinetics
  • Gas Chromatography-Mass Spectrometry / methods*
  • Humans
  • Reference Standards
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Azepines
  • clotiazepam